Los Angeles Capital Management’s Immunomedics Inc IMMU Stock Holding History

Los Angeles Capital Management’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-8,061	Closed	-$685K	–	1578
2020 Q3	$685K	Buy	+8,061	New	+$408K	﹤0.01%	957
2020 Q2	–	Sell	-18,285	Closed	-$246K	–	1544
2020 Q1	$246K	Buy	18,285 +5,842	+47%	+$98.3K	﹤0.01%	1123
2019 Q4	$263K	Sell	12,443 -810	-6%	-$14.3K	﹤0.01%	1155
2019 Q3	$176K	Sell	13,253 -37,167	-74%	-$546K	﹤0.01%	1217
2019 Q2	$699K	Buy	50,420 +19,140	+61%	+$288K	﹤0.01%	954
2019 Q1	$601K	Buy	+31,280	New	+$504K	﹤0.01%	1028

Los Angeles Capital Management's IMMU Position: Q4 2020 in Review

Los Angeles Capital Management sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 8,061 shares — an estimated $685K sold.

Los Angeles Capital Management first reported a position in IMMU in Q1 2019 and held it in 6 quarters. The position peaked at $699K in Q2 2019. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

Los Angeles Capital Management reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
Los Angeles Capital Management sold 8,061 Immunomedics Inc shares in Q4 2020, an estimated $685K.
Los Angeles Capital Management first reported a position in Immunomedics Inc in Q1 2019 and held it in 6 quarters.
Los Angeles Capital Management's Immunomedics Inc position peaked at $699K in Q2 2019.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Los Angeles Capital Management's 13F filing for Q4 2020, filed 4 Feb 2021.